Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.
Wang J, Jordan AR, Zhu H, Hasanali SL, Thomas E, Lokeshwar SD, Morera DS, Alexander S, McDaniels J, Sharma A, Aguilar K, Sarcan S, Zhu T, Soloway MS, Terris MK, Thangaraju M, Lopez LE, Lokeshwar VB. Wang J, et al. Among authors: hasanali sl. Cancer Cell Int. 2022 Dec 29;22(1):421. doi: 10.1186/s12935-022-02818-1. Cancer Cell Int. 2022. PMID: 36581895 Free PMC article.
RAD51AP1 Loss Attenuates Colorectal Cancer Stem Cell Renewal and Sensitizes to Chemotherapy.
Bridges AE, Ramachandran S, Tamizhmani K, Parwal U, Lester A, Rajpurohit P, Morera DS, Hasanali SL, Arjunan P, Jedeja RN, Patel N, Martin PM, Korkaya H, Singh N, Manicassamy S, Prasad PD, Lokeshwar VB, Lokeshwar BL, Ganapathy V, Thangaraju M. Bridges AE, et al. Among authors: hasanali sl. Mol Cancer Res. 2021 Sep;19(9):1486-1497. doi: 10.1158/1541-7786.MCR-20-0780. Epub 2021 Jun 7. Mol Cancer Res. 2021. PMID: 34099522 Free PMC article.
HYAL4-V1/Chondroitinase (Chase) Drives Gemcitabine Resistance and Predicts Chemotherapy Failure in Patients with Bladder Cancer.
Hasanali SL, Morera DS, Racine RR, Hennig M, Ghosh S, Lopez LE, Hupe MC, Escudero DO, Wang J, Zhu H, Sarcan S, Azih I, Zhou M, Jordan AR, Terris MK, Kuczyk MA, Merseburger AS, Lokeshwar VB. Hasanali SL, et al. Clin Cancer Res. 2021 Aug 1;27(15):4410-4421. doi: 10.1158/1078-0432.CCR-21-0422. Epub 2021 May 24. Clin Cancer Res. 2021. PMID: 34031055
Promotion of epithelial hyperplasia by interleukin-8-CXCR axis in human prostate.
Smith DK, Hasanali SL, Wang J, Kallifatidis G, Morera DS, Jordan AR, Terris MK, Klaassen Z, Bollag R, Lokeshwar VB, Lokeshwar BL. Smith DK, et al. Among authors: hasanali sl. Prostate. 2020 Sep;80(12):938-949. doi: 10.1002/pros.24026. Epub 2020 Jun 16. Prostate. 2020. PMID: 32542667 Free PMC article.
Molecular targeting of renal cell carcinoma by an oral combination.
Jordan AR, Wang J, Yates TJ, Hasanali SL, Lokeshwar SD, Morera DS, Shamaladevi N, Li CS, Klaassen Z, Terris MK, Thangaraju M, Singh AB, Soloway MS, Lokeshwar VB. Jordan AR, et al. Among authors: hasanali sl. Oncogenesis. 2020 May 19;9(5):52. doi: 10.1038/s41389-020-0233-0. Oncogenesis. 2020. PMID: 32427869 Free PMC article.
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.
Lokeshwar VB, Morera DS, Hasanali SL, Yates TJ, Hupe MC, Knapp J, Lokeshwar SD, Wang J, Hennig MJP, Baskar R, Escudero DO, Racine RR, Dhir N, Jordan AR, Hoye K, Azih I, Manoharan M, Klaassen Z, Kavuri S, Lopez LE, Ghosh S, Lokeshwar BL. Lokeshwar VB, et al. Among authors: hasanali sl. Clin Cancer Res. 2020 Jul 1;26(13):3455-3467. doi: 10.1158/1078-0432.CCR-19-2912. Epub 2020 Feb 24. Clin Cancer Res. 2020. PMID: 32094233 Free PMC article.
Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA.
Morera DS, Hasanali SL, Belew D, Ghosh S, Klaassen Z, Jordan AR, Wang J, Terris MK, Bollag RJ, Merseburger AS, Stenzl A, Soloway MS, Lokeshwar VB. Morera DS, et al. Among authors: hasanali sl. J Urol. 2020 Jan;203(1):62-72. doi: 10.1097/JU.0000000000000351. Epub 2019 May 21. J Urol. 2020. PMID: 31112107 Free PMC article.